News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
245,326 Results
Type
Article (5841)
Company Profile (20)
Press Release (239465)
Section
Business (87666)
Career Advice (470)
Deals (16475)
Drug Delivery (9)
Drug Development (21233)
Employer Resources (32)
FDA (4053)
Job Trends (4550)
News (129823)
Policy (8499)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (2)
2025 Lone Star Bio Digital (1)
Academia (336)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (16197)
ALS (22)
Alzheimer's disease (317)
Antibody-drug conjugate (ADC) (15)
Approvals (4075)
Artificial intelligence (48)
Autoimmune disease (5)
Automation (3)
Bankruptcy (107)
Best Places to Work (3387)
Biosimilars (12)
Biotechnology (28)
Bladder cancer (11)
Brain cancer (8)
Breast cancer (71)
Cancer (521)
Cardiovascular disease (27)
Career advice (402)
Career pathing (3)
CAR-T (33)
Cell therapy (111)
Cervical cancer (2)
Clinical research (17780)
Collaboration (196)
Compensation (171)
Complete response letters (3)
COVID-19 (450)
CRISPR (8)
C-suite (114)
Cystic fibrosis (17)
Data (594)
Depression (8)
Diabetes (49)
Diagnostics (2255)
Digital health (3)
Diversity, equity & inclusion (13)
Drug discovery (26)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (12)
Earnings (42863)
Editorial (2)
Employer branding (6)
Employer resources (33)
Events (40541)
Executive appointments (334)
FDA (4327)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (226)
Gene editing (17)
Generative AI (2)
Gene therapy (53)
GLP-1 (125)
Government (522)
Guidances (18)
Healthcare (5570)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (469)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (57)
IPO (8405)
IRA (3)
Job creations (1260)
Job search strategy (365)
Kidney cancer (7)
Labor market (5)
Layoffs (107)
Leadership (5)
Legal (2717)
Liver cancer (17)
Lung cancer (58)
Lymphoma (33)
Management (11)
Manufacturing (57)
MASH (28)
Medical device (4303)
Medtech (4305)
Mergers & acquisitions (8309)
Metabolic disorders (132)
Multiple sclerosis (12)
NASH (6)
Neurodegenerative disease (12)
Neuropsychiatric disorders (2)
Neuroscience (431)
NextGen: Class of 2025 (1793)
Non-profit (790)
Northern California (961)
Now hiring (3)
Obesity (55)
Opinion (31)
Ovarian cancer (17)
Pain (16)
Pancreatic cancer (20)
Parkinson's disease (29)
Partnered (8)
Patents (28)
Patient recruitment (33)
Peanut (5)
People (26457)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (5269)
Phase II (7831)
Phase III (6119)
Pipeline (584)
Policy (9)
Postmarket research (660)
Preclinical (2094)
Press Release (67)
Prostate cancer (29)
Psychedelics (5)
Radiopharmaceuticals (120)
Rare diseases (75)
Real estate (2015)
Recruiting (9)
Regulatory (5676)
Reports (15)
Research institute (351)
Resumes & cover letters (68)
Rett syndrome (4)
RNA editing (1)
Schizophrenia (26)
Series A (30)
Series B (23)
Service/supplier (2)
Sickle cell disease (8)
Southern California (730)
Special edition (1)
Spinal muscular atrophy (30)
Sponsored (5)
Startups (1123)
State (1)
Stomach cancer (1)
Supply chain (12)
Tariffs (5)
United States (7718)
Vaccines (59)
Venture capitalists (3)
Weight loss (23)
Women's health (1)
Date
Today (39)
Last 7 days (243)
Last 30 days (787)
Last 365 days (11084)
2025 (3514)
2024 (12208)
2023 (14509)
2022 (20474)
2021 (21860)
2020 (19716)
2019 (14307)
2018 (11012)
2017 (10871)
2016 (10001)
2015 (13155)
2014 (10372)
2013 (8354)
2012 (9045)
2011 (9449)
2010 (9259)
Location
Africa (199)
Alabama (14)
Alaska (2)
Arizona (66)
Arkansas (1)
Asia (12186)
Australia (1675)
California (2031)
Canada (1101)
China (79)
Colorado (92)
Connecticut (99)
Delaware (35)
Europe (25942)
Florida (295)
Georgia (39)
Idaho (23)
Illinois (119)
India (7)
Indiana (81)
Iowa (2)
Japan (78)
Kansas (25)
Kentucky (11)
Louisiana (5)
Maine (40)
Maryland (228)
Massachusetts (1655)
Michigan (105)
Minnesota (147)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (14)
Nevada (26)
New Hampshire (24)
New Jersey (711)
New Mexico (8)
New York (533)
North Carolina (355)
North Dakota (3)
Northern California (961)
Ohio (60)
Oklahoma (7)
Oregon (4)
Pennsylvania (389)
Puerto Rico (2)
Rhode Island (13)
South America (307)
South Carolina (5)
Southern California (730)
Tennessee (44)
Texas (278)
Utah (64)
Virginia (46)
Washington D.C. (9)
Washington State (182)
West Virginia (2)
Wisconsin (34)
245,326 Results for "apotex corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Apotex Corp. Launches Generic Fertility Treatment Injectable Cetrorelix® in the United States
Apotex Corp. announced the launch of Cetrorelix Acetate for Injection 0.25mg, a generic version of Cetrotide® in the United States.
May 14, 2024
·
1 min read
Press Releases
Apotex Corp. is the first generic manufacturer to launch dasatinib tablets in the United States
September 4, 2024
·
1 min read
BioMidwest
Apotex Corp. Launches Teriparatide Injectable for Osteoporosis Treatment in the United States
Apotex Corp. announced the launch of Teriparatide Injection, a single-patient-use pre-filled pen used for the treatment of osteoporosis in the United States.
November 21, 2023
·
1 min read
Press Releases
Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal
February 25, 2025
·
4 min read
Press Releases
Apotex acquires US rights to PROVIGIL® (modafinil) and NUVIGIL® (armodafinil)
January 9, 2025
·
2 min read
Apotex Corp. Launches Brimonidine Tartrate Ophthalmic Solution, 0.1% in the United States
Apotex Corp. has released its latest ophthalmic product in the United States, announcing today that brimonidine tartrate ophthalmic solution, 0.1% is now available.
September 5, 2023
·
1 min read
Deals
Apotex to Acquire Searchlight Pharma, a Canadian Specialty Branded Pharmaceutical Leader
Canada’s largest pharmaceutical company, Apotex Inc. and Searchlight Pharma Inc. (“Searchlight”), one of Canada’s fastest growing companies, announced today that they have reached an agreement whereby Apotex will acquire Searchlight.
April 2, 2024
·
4 min read
Apotex Corp. Launches Bendamustine Hydrochloride Injection in the United States
Apotex Corp. has expanded its oncology product portfolio with the launch of Bendamustine hydrochloride injection in the United States.
April 26, 2023
·
1 min read
Apotex to Participate in the Jefferies Global Healthcare Conference 2024
Apotex Inc. announced that Allan Oberman, President & CEO, will be presenting at the Jefferies Healthcare Conference on Wednesday, June 5th, 2024 at 9:00 am EST in New York, NY.
June 4, 2024
·
1 min read
Deals
Apotex Completes Acquisition of Searchlight, a leading Canadian-based Specialty Innovative Branded Pharmaceutical Company
TORONTO, June 3, 2024 /PRNewswire/ - Apotex Inc. announced the successful completion of its acquisition of Searchlight Pharma Inc., a leading Canadian specialty innovative branded pharmaceutical company.
June 3, 2024
·
2 min read
1 of 24,533
Next
